Symbols / EWTX Stock $32.17 -0.86% Edgewise Therapeutics, Inc.
EWTX (Stock) Chart
About
No company description available for this symbol.
Stock Fundamentals
Scroll to Statements| Market Cap | 3.45B | Enterprise Value | — | Income | — | Sales | — | Book/sh | — | Cash/sh | — |
| Dividend Yield | — | Payout | — | Employees | — | IPO | — | P/E | — | Forward P/E | — |
| PEG | — | P/S | — | P/B | — | P/C | — | EV/EBITDA | — | EV/Sales | — |
| Quick Ratio | — | Current Ratio | — | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | — | EPS next Y | — |
| EPS Growth | — | Revenue Growth | — | Earnings | — | ROA | — | ROE | — | ROIC | — |
| Gross Margin | — | Oper. Margin | — | Profit Margin | — | Shs Outstand | — | Shs Float | — | Short Float | — |
| Short Ratio | — | Short Interest | — | 52W High | — | 52W Low | — | Beta | — | Avg Volume | — |
| Volume | — | Target Price | — | Recom | — | Prev Close | $32.45 | Price | $32.17 | Change | -0.86% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
- Edgewise Therapeutics (EWTX) Stock: What Investors Should Know | Q4 2025: Profit Disappoints - Stock Market Community - Cổng thông tin điện tử tỉnh Tây Ninh hu, 23 Apr 2026 01
- Edgewise Therapeutics CMO sells $926,095 in EWTX stock - Investing.com hu, 02 Apr 2026 07
- Discipline and Rules-Based Execution in EWTX Response - Stock Traders Daily Mon, 20 Apr 2026 21
- Director at Edgewise Therapeutics (EWTX) awarded 339 new shares - Stock Titan Fri, 03 Apr 2026 07
- Edgewise Therapeutics, Inc. (EWTX) PT Increased to $45 at JPMorgan Amid Optimism on EDG-7500 Pipeline - Yahoo Finance Mon, 30 Mar 2026 07
- $EWTX stock is down 10% today. Here's what we see in our data. - Quiver Quantitative hu, 18 Dec 2025 08
- Why Edgewise Therapeutics Stock Is Surging Today - TipRanks ue, 21 Apr 2026 11
- Edgewise Therapeutics CMO Donovan sells $506k in EWTX stock - Investing.com Mon, 30 Mar 2026 07
- Edgewise gives 4 new hires stock options for 72,000 shares - Stock Titan Wed, 01 Apr 2026 07
- Assessing Edgewise Therapeutics (EWTX) Valuation After Strong Multi‑Year Returns And Recent Share Price Momentum - Yahoo Finance hu, 26 Feb 2026 08
- Edgewise Therapeutics CMO sells $685k in EWTX stock - Investing.com ue, 31 Mar 2026 07
- What is the price target for Edgewise Therapeutics (EWTX) Stock | Price at $33.22, Up 1.22% - Shared Momentum Picks - UBND thành phố Hải Phòng Mon, 13 Apr 2026 07
- Edgewise Therapeutics (NASDAQ: EWTX) CMO sells 16,358 shares in open market - Stock Titan Mon, 30 Mar 2026 07
- Assessing Edgewise Therapeutics (EWTX) Valuation After Recent Share Price Momentum - Yahoo Finance hu, 12 Feb 2026 08
- Edgewise Therapeutics (EWTX) CMO sells 21,338 shares after option exercise - Stock Titan ue, 31 Mar 2026 07
Insider Transactions
No recent insider transactions.
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
191.41
+20.51%
|
158.83
+38.89%
|
114.36
+59.59%
|
71.66
|
| Research And Development |
|
151.39
+19.24%
|
126.97
+39.67%
|
90.91
+68.24%
|
54.03
|
| Selling General And Administration |
|
40.02
+25.58%
|
31.87
+35.88%
|
23.45
+33.05%
|
17.63
|
| General And Administrative Expense |
|
40.02
+25.58%
|
31.87
+35.88%
|
23.45
+33.05%
|
17.63
|
| Other Gand A |
|
40.02
+25.58%
|
31.87
+35.88%
|
23.45
+33.05%
|
17.63
|
| Total Expenses |
|
191.41
+20.51%
|
158.83
+38.89%
|
114.36
+59.59%
|
71.66
|
| Operating Income |
|
-191.41
-20.51%
|
-158.83
-38.89%
|
-114.36
-59.59%
|
-71.66
|
| Total Operating Income As Reported |
|
-191.41
-20.51%
|
-158.83
-38.89%
|
-114.36
-59.59%
|
-71.66
|
| EBITDA |
|
-189.14
-20.82%
|
-156.54
-38.99%
|
-112.62
-58.36%
|
-71.12
|
| Normalized EBITDA |
|
-189.14
-20.82%
|
-156.54
-38.99%
|
-112.62
-58.36%
|
-71.12
|
| Reconciled Depreciation |
|
2.27
-1.05%
|
2.29
+32.22%
|
1.73
+221.93%
|
0.54
|
| EBIT |
|
-191.41
-20.51%
|
-158.83
-38.89%
|
-114.36
-59.59%
|
-71.66
|
| Net Income |
|
-167.79
-25.40%
|
-133.81
-33.60%
|
-100.16
-48.08%
|
-67.64
|
| Pretax Income |
|
-167.79
-25.40%
|
-133.81
-33.60%
|
-100.16
-48.08%
|
-67.64
|
| Net Non Operating Interest Income Expense |
|
23.61
-5.63%
|
25.02
+76.26%
|
14.19
+253.26%
|
4.02
|
| Net Interest Income |
|
23.61
-5.63%
|
25.02
+76.26%
|
14.19
+253.26%
|
4.02
|
| Interest Income Non Operating |
|
23.61
-5.63%
|
25.02
+76.26%
|
14.19
+253.26%
|
4.02
|
| Interest Income |
|
23.61
-5.63%
|
25.02
+76.26%
|
14.19
+253.26%
|
4.02
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-167.79
-25.40%
|
-133.81
-33.60%
|
-100.16
-48.08%
|
-67.64
|
| Net Income From Continuing Operation Net Minority Interest |
|
-167.79
-25.40%
|
-133.81
-33.60%
|
-100.16
-48.08%
|
-67.64
|
| Net Income From Continuing And Discontinued Operation |
|
-167.79
-25.40%
|
-133.81
-33.60%
|
-100.16
-48.08%
|
-67.64
|
| Net Income Continuous Operations |
|
-167.79
-25.40%
|
-133.81
-33.60%
|
-100.16
-48.08%
|
-67.64
|
| Normalized Income |
|
-167.79
-25.40%
|
-133.81
-33.60%
|
-100.16
-48.08%
|
-67.64
|
| Net Income Common Stockholders |
|
-167.79
-25.40%
|
-133.81
-33.60%
|
-100.16
-48.08%
|
-67.64
|
| Diluted EPS |
|
—
|
-0.42
+73.25%
|
-1.57
-406.45%
|
-0.31
|
| Basic EPS |
|
—
|
-0.42
+73.25%
|
-1.57
-406.45%
|
-0.31
|
| Basic Average Shares |
|
—
|
94.72
+48.64%
|
63.72
+0.78%
|
63.23
|
| Diluted Average Shares |
|
—
|
94.72
+48.64%
|
63.72
+0.78%
|
63.23
|
| Diluted NI Availto Com Stockholders |
|
-167.79
-25.40%
|
-133.81
-33.60%
|
-100.16
-48.08%
|
-67.64
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
552.60
+13.51%
|
486.82
+43.17%
|
340.04
-7.37%
|
367.10
|
| Current Assets |
|
543.38
+14.28%
|
475.48
+45.41%
|
327.00
-8.40%
|
357.00
|
| Cash Cash Equivalents And Short Term Investments |
|
530.11
+12.75%
|
470.17
+47.67%
|
318.39
-9.53%
|
351.95
|
| Cash And Cash Equivalents |
|
61.15
+46.76%
|
41.67
-51.61%
|
86.10
+291.47%
|
21.99
|
| Other Short Term Investments |
|
468.96
+9.44%
|
428.50
+84.46%
|
232.30
-29.60%
|
329.95
|
| Prepaid Assets |
|
—
|
—
|
—
|
5.05
|
| Other Current Assets |
|
13.28
+149.88%
|
5.31
-38.25%
|
8.60
+70.31%
|
5.05
|
| Total Non Current Assets |
|
9.22
-18.67%
|
11.33
-13.07%
|
13.04
+29.06%
|
10.10
|
| Net PPE |
|
9.22
-16.74%
|
11.07
-12.75%
|
12.69
+28.82%
|
9.85
|
| Gross PPE |
|
15.99
+1.46%
|
15.76
+2.95%
|
15.31
+40.22%
|
10.92
|
| Accumulated Depreciation |
|
-6.77
-44.48%
|
-4.68
-79.09%
|
-2.62
-145.63%
|
-1.06
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
0.81
+0.00%
|
0.81
+3.73%
|
0.78
+176.87%
|
0.28
|
| Construction In Progress |
|
0.08
|
0.00
-100.00%
|
0.08
-98.91%
|
7.34
|
| Other Properties |
|
5.46
+2.88%
|
5.30
-7.27%
|
5.72
+73.49%
|
3.30
|
| Leases |
|
9.65
+0.00%
|
9.65
+10.52%
|
8.73
|
0.00
|
| Other Non Current Assets |
|
—
|
0.26
-24.71%
|
0.35
+38.65%
|
0.25
|
| Total Liabilities Net Minority Interest |
|
30.35
+9.95%
|
27.60
+30.16%
|
21.20
+4.02%
|
20.39
|
| Current Liabilities |
|
27.37
+14.71%
|
23.86
+42.27%
|
16.77
+1.12%
|
16.59
|
| Payables And Accrued Expenses |
|
13.93
+8.73%
|
12.81
+26.86%
|
10.10
-15.48%
|
11.95
|
| Payables |
|
6.01
+7.65%
|
5.58
+38.61%
|
4.03
-34.07%
|
6.11
|
| Accounts Payable |
|
6.01
+7.65%
|
5.58
+38.61%
|
4.03
-34.07%
|
6.11
|
| Current Accrued Expenses |
|
7.92
+9.56%
|
7.23
+19.07%
|
6.07
+3.96%
|
5.84
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
12.43
+23.61%
|
10.06
+76.58%
|
5.70
+41.25%
|
4.03
|
| Current Debt And Capital Lease Obligation |
|
1.01
+1.81%
|
1.00
+1.63%
|
0.98
+61.18%
|
0.61
|
| Current Capital Lease Obligation |
|
1.01
+1.81%
|
1.00
+1.63%
|
0.98
+61.18%
|
0.61
|
| Total Non Current Liabilities Net Minority Interest |
|
2.98
-20.45%
|
3.74
-15.63%
|
4.43
+16.68%
|
3.80
|
| Long Term Debt And Capital Lease Obligation |
|
2.98
-20.45%
|
3.74
-15.63%
|
4.43
+16.68%
|
3.80
|
| Long Term Capital Lease Obligation |
|
2.98
-20.45%
|
3.74
-15.63%
|
4.43
+16.68%
|
3.80
|
| Other Non Current Liabilities |
|
—
|
—
|
—
|
—
|
| Preferred Securities Outside Stock Equity |
|
—
|
—
|
—
|
—
|
| Stockholders Equity |
|
522.26
+13.73%
|
459.22
+44.03%
|
318.83
-8.04%
|
346.72
|
| Common Stock Equity |
|
522.26
+13.73%
|
459.22
+44.03%
|
318.83
-8.04%
|
346.72
|
| Capital Stock |
|
0.01
+11.11%
|
0.01
+28.57%
|
0.01
+16.67%
|
0.01
|
| Common Stock |
|
0.01
+11.11%
|
0.01
+28.57%
|
0.01
+16.67%
|
0.01
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
106.25
+12.03%
|
94.84
+34.61%
|
70.45
+11.38%
|
63.26
|
| Ordinary Shares Number |
|
106.25
+12.03%
|
94.84
+34.61%
|
70.45
+11.38%
|
63.26
|
| Additional Paid In Capital |
|
1,067.94
+27.54%
|
837.36
+48.60%
|
563.49
+14.38%
|
492.67
|
| Retained Earnings |
|
-546.37
-44.32%
|
-378.58
-54.67%
|
-244.76
-69.27%
|
-144.60
|
| Gains Losses Not Affecting Retained Earnings |
|
0.68
+61.19%
|
0.42
+324.24%
|
0.10
+107.31%
|
-1.35
|
| Other Equity Adjustments |
|
0.68
+61.19%
|
0.42
+324.24%
|
0.10
+107.31%
|
-1.35
|
| Total Equity Gross Minority Interest |
|
522.26
+13.73%
|
459.22
+44.03%
|
318.83
-8.04%
|
346.72
|
| Total Capitalization |
|
522.26
+13.73%
|
459.22
+44.03%
|
318.83
-8.04%
|
346.72
|
| Working Capital |
|
516.01
+14.26%
|
451.62
+45.58%
|
310.23
-8.87%
|
340.41
|
| Invested Capital |
|
522.26
+13.73%
|
459.22
+44.03%
|
318.83
-8.04%
|
346.72
|
| Total Debt |
|
3.99
-15.77%
|
4.74
-12.50%
|
5.41
+22.82%
|
4.41
|
| Capital Lease Obligations |
|
3.99
-15.77%
|
4.74
-12.50%
|
5.41
+22.82%
|
4.41
|
| Net Tangible Assets |
|
522.26
+13.73%
|
459.22
+44.03%
|
318.83
-8.04%
|
346.72
|
| Tangible Book Value |
|
522.26
+13.73%
|
459.22
+44.03%
|
318.83
-8.04%
|
346.72
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-143.82
-31.91%
|
-109.03
-18.58%
|
-91.95
-74.69%
|
-52.63
|
| Cash Flow From Continuing Operating Activities |
|
-143.82
-31.91%
|
-109.03
-18.58%
|
-91.95
-74.69%
|
-52.63
|
| Net Income From Continuing Operations |
|
-167.79
-25.40%
|
-133.81
-33.60%
|
-100.16
-48.08%
|
-67.64
|
| Depreciation Amortization Depletion |
|
2.27
-1.05%
|
2.29
+32.22%
|
1.73
+221.93%
|
0.54
|
| Depreciation |
|
2.27
-1.05%
|
2.29
+32.22%
|
1.73
+221.93%
|
0.54
|
| Depreciation And Amortization |
|
2.27
-1.05%
|
2.29
+32.22%
|
1.73
+221.93%
|
0.54
|
| Stock Based Compensation |
|
34.75
+40.63%
|
24.71
+40.73%
|
17.56
+60.75%
|
10.92
|
| Change In Working Capital |
|
-5.37
-152.03%
|
10.33
+762.05%
|
-1.56
-138.18%
|
4.09
|
| Change In Prepaid Assets |
|
-7.96
-341.89%
|
3.29
+192.65%
|
-3.55
-144.70%
|
-1.45
|
| Change In Payables And Accrued Expense |
|
3.34
-54.01%
|
7.26
+246.02%
|
2.10
-19.90%
|
2.62
|
| Change In Accrued Expense |
|
3.06
-44.46%
|
5.52
+152.12%
|
2.19
-14.86%
|
2.57
|
| Change In Payable |
|
0.27
-84.34%
|
1.74
+1988.04%
|
-0.09
-295.74%
|
0.05
|
| Change In Account Payable |
|
0.27
-84.34%
|
1.74
+1988.04%
|
-0.09
-295.74%
|
0.05
|
| Change In Other Working Capital |
|
—
|
—
|
—
|
1.24
|
| Change In Other Current Liabilities |
|
-0.75
-240.00%
|
-0.22
-111.54%
|
-0.10
-103.56%
|
2.92
|
| Investing Cash Flow |
|
-32.79
+82.24%
|
-184.66
-279.48%
|
102.89
+245.78%
|
-70.58
|
| Cash Flow From Continuing Investing Activities |
|
-32.79
+82.24%
|
-184.66
-279.48%
|
102.89
+245.78%
|
-70.58
|
| Net PPE Purchase And Sale |
|
-0.26
+80.49%
|
-1.31
+77.16%
|
-5.75
-3.59%
|
-5.55
|
| Purchase Of PPE |
|
-0.26
+80.49%
|
-1.31
+77.16%
|
-5.75
-3.59%
|
-5.55
|
| Capital Expenditure |
|
-0.26
+80.49%
|
-1.31
+77.16%
|
-5.75
-3.59%
|
-5.55
|
| Net Investment Purchase And Sale |
|
-32.53
+82.26%
|
-183.34
-268.78%
|
108.63
+267.04%
|
-65.03
|
| Purchase Of Investment |
|
-527.23
-10.52%
|
-477.06
-86.45%
|
-255.87
+12.49%
|
-292.39
|
| Sale Of Investment |
|
494.69
+68.43%
|
293.71
-19.42%
|
364.50
+60.32%
|
227.36
|
| Financing Cash Flow |
|
196.09
-21.33%
|
249.25
+368.82%
|
53.17
-58.99%
|
129.64
|
| Cash Flow From Continuing Financing Activities |
|
196.09
-21.33%
|
249.25
+368.82%
|
53.17
-58.99%
|
129.64
|
| Net Common Stock Issuance |
|
187.36
-21.65%
|
239.15
+354.50%
|
52.62
-59.26%
|
129.16
|
| Proceeds From Stock Option Exercised |
|
8.73
-15.84%
|
10.37
+1354.14%
|
0.71
-1.66%
|
0.72
|
| Net Other Financing Charges |
|
—
|
-0.26
-58.79%
|
-0.17
+34.26%
|
-0.25
|
| Changes In Cash |
|
19.48
+143.85%
|
-44.43
-169.31%
|
64.10
+897.42%
|
6.43
|
| Beginning Cash Position |
|
41.67
-51.61%
|
86.10
+291.47%
|
21.99
+41.29%
|
15.57
|
| End Cash Position |
|
61.15
+46.76%
|
41.67
-51.61%
|
86.10
+291.47%
|
21.99
|
| Free Cash Flow |
|
-144.07
-30.57%
|
-110.34
-12.95%
|
-97.69
-67.91%
|
-58.18
|
| Amortization Of Securities |
|
-7.67
+38.90%
|
-12.54
-31.82%
|
-9.52
-1652.67%
|
-0.54
|
| Common Stock Issuance |
|
187.36
-21.65%
|
239.15
+354.50%
|
52.62
-59.26%
|
129.16
|
| Issuance Of Capital Stock |
|
187.36
-21.65%
|
239.15
+354.50%
|
52.62
-59.26%
|
129.16
|
| Net Preferred Stock Issuance |
|
—
|
—
|
—
|
—
|
| Preferred Stock Issuance |
|
—
|
—
|
—
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-03 View
- 42026-04-02 View
- 42026-03-31 View
- 42026-03-30 View
- 10-K2026-02-26 View
- 8-K2026-02-26 View
- 42026-01-23 View
- 42026-01-05 View
- 42025-11-24 View
- 8-K2025-11-20 View
- 42025-11-13 View
- 42025-11-13 View
- 42025-11-13 View
- 8-K2025-11-10 View
- 10-Q2025-11-06 View
- 8-K2025-11-06 View
- 42025-10-02 View
- 42025-08-28 View
- 42025-08-14 View
- 42025-08-14 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|